Fatty Liver Disease Is Actually Five Distinct Conditions, Researchers Find
Fatty liver disease, a condition affecting roughly 30% of adults worldwide, may be far more complex than previously understood. Researchers at the Mayo Clinic have discovered that what doctors have long considered a single disease is actually five distinct biological subtypes, each carrying different risk profiles for serious complications.
The discovery could have significant implications for patient care. Until now, fatty liver disease has been treated as one condition, but the new research suggests that patients with different subtypes may face varying risks of liver failure, cancer, heart disease, and other complications.
Identifying which subtype a patient has could help doctors predict disease progression more accurately and tailor treatment strategies accordingly. This personalized approach mirrors a broader trend in medicine toward subtype-specific diagnostics and therapies.
The findings highlight how even common diseases can harbor hidden complexity beneath their seemingly uniform surface. As researchers continue to study these five subtypes, the medical community may need to revisit current screening guidelines and treatment protocols for fatty liver disease.